Molecular cloning and functional expression of a potassium channel cDNA isolated from a rat cardiac library  by Tseng-Crank, Julie C.L. et al.
Volume 268, number 1,63-68 FEBS 08661 July 1990 
Molecular cloning and functional expression of a potassium channel 
cDNA isolated from a rat cardiac library 
Julie C.L. Tseng-Crank 13, Gea-Ny Tseng, Arnold Schwati, and Mark A. Tanouyel 
~~ivisio~ of Biology, ~o~i~or~i~ fmtitute of Tec~ology, Patina, CA 91125, USA, zDe~rtment of Pharmacology, College of 
~hy~ic~a~ and surgeons, Col~bia University, 630 West 168th Street, New York, NY ~~32, USA and 3~epartment of 
Pharmacology and Cell ~io~hy~~s, University of Cincinnati Coilege of Medicine, 231 Bethesda Avenue, Cincinnati, OH 45267-0575, 
USA 
Received 14 April 1990; revised version received 29 May 1990 
A full-length K+ channel cDNA (RHKI) was isolated from a rat cardiac library using the polymerasc chain reaction (PCR) method and degenerate 
oligonucleotide primers derived from K” channel sequences conserved between Drosophila Shaker H4 and mouse brain MBKl. Although RHKl 
was isolated from heart, its expression was found in both heart and brain. The RHKl-encoded protein, when expressed in Xenopus oocytes, gated 
a 4aminopyridine (4-AP)-sensitive transient outward current. This current is similar to the transient outward current measured in rat ventricular 
myocytes with respect o voltage-dependence of activation and inactivation, time course of activation and inactivation, and pharmacology. 
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1. INTRODUCTION molecular analysis of cardiac K+ channels by cloning a 
cDNA expressed in rat heart. 
Electrophysiological studies suggest hat there are at 
least 10 distinct K+ conductances in the heart [l-lo]. 
These conductances appear to be critical for the deter- 
mination of various phases during the cardiac excita- 
tion cycle, especially phase 1 repolarization, phase 3 
repolarization, and resting membrane potential. A 
molecular understan~ng of cardiac Ki ch~nels 
should give fundamental insight into mechanisms 
underlying the normal cardiac action potential, and 
how this excitability may be altered by pathology or by 
drugs [I 11. Of particular interest is the contribution that 
ischemia-induced alterations in K ’ conductance or K + 
accumulation may play in reentry arrhythmias. A 
related issue of therapeutic interest is the differential ex- 
pression of K + channels in heart versus other excitable 
tissues. Some antiarrhythmic drugs appear to exert their 
action by modif~ng cardiac K” channels, but their 
usefulness has been limited by an apparent lack of seiec- 
tivity f 121. If so, molecular analyses of cardiac channels 
could provide a basis for the design of more specific 
agents [ 131. Cardiac K + channels have generally been 
viewed as being distinct from their brain counterparts, 
however, it is possible that all major cardiac channels 
show substantial expression in other excitable tissues. 
To address some of these issues, we have initiated a 
2. MATERIALS AND METHODS 
2.1. PCR cloning and sequencing of cDNAs 
Degenerate oligonucl~tides (20 bases) to prime a PCR amplifica- 
tion were synthesized according to the Dro~ophiIa Shaker H4 cDNA 
sequence: a sense sequence co~esponded to amino acid residues 
413-419 and an antisense sequence corresponded to residues 480-486 
[14]. The amino acid sequences are identical between Shaker and 
mouse MBKl (151. Template was recombinant lambda phage DNA 
from a rat cardiac cDNA library prepared by Clontech from adult rat 
heart poly(A) + RNA. 1.6 x lo6 independent clones were divided into 
7 pools and amplified in separate runs: 94’C, 1 min; 4S”C, 1 min; and 
WC, 2 min for 40 cycles using Taq DNA polymerase. Amplified pro- 
ducts from the PCR were size-fractionated, isolated, cloned into 
pBluescript vector (Stratagene), and sequenced using a Sequenase kit 
(US Biochemical Co.). Sequence data were analyzed on an IBM-XT 
with software developed by Dr A. Goldin, Caltech. A small PCR 
clone corresponding to RHKl was used as a hybridization probe to 
screen the rat heart cDNA library. Twenty~ight cDNAs were 
isolated, and we chose 2 with large inserts, RHKla and RHKlb, to ex- 
amine in detail. All of the cDNA sequencing was performed using 
both dGTP and 7-deazo-dGTP reactions. In the consensus RHKl se- 
quence (3201 bp), RHKla extends from nucleotides 1 to 3122 and 
contains the entire open reading frame; RHKlb is an incomplete 
cDNA, and extends from 1342 to 3201. An initiation sequence used 
by eukaryotic ribosomes (ACCATGG) is present at the putative 
RHKl initiation codon 1161. 
2.2. Synthesis of cRNA and Xenopus oocyte expression 
Correspondence address:J.C.L. Tseng-Crank, Department of Phar- 
macology and Cell Biophysics, University of Cincinnati College of 
Medicine, 231 Bethesda Avenue, Cincinnati, OH 45267-0575, USA 
To prepare transcripts, RHKla was subcloned into the EcoRi site 
of the pBluescript vector under control of the T7 promoter. Template 
DNA was prepared by digestion with Hind111 followed by proteinase 
K treatment. A Pharmacia TransProbe T kit was used for the 
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RHKl MEVAMVSAESSGCNSHMPYGYAAQARARERERLAHSRAAAALAVAAATAAVEGTGGSGGGPHHHHQTRGA ‘O 
P 
RHKl YSSHDPQGSRGSRRRRRQRTEKKKLHHRQS~FPHCSDLMPSGSEEKILREL~EEEEDEEEEEEEEEEGRF 140 
Sh H4 
RHKl YYSEEDHGDCCSYTDLLPQDDGGGGGYSSVRYSDCCERWIQFPETLLGDP~KRT 210 
MBKl MTVMSGENADEAS-APGHPQ--SYPRQADHDDHE---------I--------L-------N----N-K--M 70 
RCKl MTVMSGENADEASAAPGHPQ--SYPRQADHDDHDDHE--------I--------L-------N----N-K--M 70 
RBK2 MTVATGDPVDEAAALPGHPQDTSDPE AD QE--------I--------L---_-_---_--_-K-_M 66 
Sh H4 GSLPKLSSQDEEGGAGHGFG-PQHFEPIPHDH-F----------------LR--N---D------AR-L 130 
RHKl QYFDPLRNEYFFDRNRPSFDAILYWQSGGRLKRPVNVPFDIFTEEVKFYQLGEEALLKFREDEGFVREE 280 
MBKl R_---~-~_--_~_~----~-~---_~_---~R~-_--~L~”-S-~I-_-E--_-~~_~_-~_~_IK_~ 140 
RCKl R----~-~----~_~----~----~-~----~R~----~L~N-S-~I-_-E--_-_~-~_-~_~_~K_- 140 
RBKP R----_--------_-_--_--F---------R-----_L---S--IR--~-----~M-_-_--y~K-~ 136 
Sh H4 ~---------_---~-----------~-----~------~-~-~--~---~--~Q_~~-~_-~-~_~~_~ 200 
RHKl EDRALPENEFKKQIWLLFEYPESSSP 
MBKl 
RCKl -R P---K-YQR-V----------G-- 
RBKP 
Sh H4 -R p--D--KQmV--------m-Q+ 
RHKl 
MBKl 
RCKl 
RBK2 
Sh H4 
RHKl 
MBKl 
RCKl 
RBK2 
Sh H4 
RHKl 
MBKl 
RCKl 
RBK2 
Sh H4 
LLtDTSAPHLENSGHTIFND FIVETVCIVWFSFEFVVRCF PSQALFFKN MNIIDIVSILPYFI% 
ID-T-VIYT SN --T-~~~~I~~~~~~I:I]~I~~~~~~~~~~~~ 
ID-T-VIYT SN --T- _-_KTD---_ --F----A-~-_-_-- 
YS-S-IGYQQSN S-T- ---0_-L--I------L--F- 
-G-KIEEDEVPDIT _ --LI--L--I--T--LT--FL _-NKLN-CRD --V---IA-I------ 
AEKPEDAQ-G----- 
EEDTLNLPKAPVSPQDKSSN---- 
-_---------_------- _------_-- 
-_----_-_---------- _~_~S__S_-____-_-__S_-____-__y_V_I_-_ _--------- 
-_----_-_----_----- 
-GSENSF-K--------- -------0_-_-T-V&W-e _--------- 
420 
269 
269 
270 
327 
480 
327 
327 
329 
397 
550 
397 
397 
399 
467 
RkiKl NFNYFYHRETENEEQTQLTQNAV SCPYLPSNLL KKFR!S:SSSLGDKSEYLEMEEG 618 
MBKl ---------- -----_-----G---A--LHVSS -N-A-DSDLS R---STI-KSEYM-IE-DMNN 463 
RCKl ---------- ----------_G-_-A-_LHVSS -N-A-DSDLS R---STI-KSEYM-IE-DMNN 463 
RBK2 --_-_------G---A-YL-VTS --KI--SPDL--S--A-TI-KS-YM-IQ-GVNN 467 
Sh H4 -_----_-_- ----------DQ--MQSQNF-H-T------GT-VGQHMKK 537 
RHKl VKESLCGKEEKCQGKGDDSETDKNNCSNAKAVETDV 654 
MBKl SIAHYRQANIRTGNCTTADQNCV -K-KL L--_ 495 
RCK 1 SIAHYRQANIRTGNCTATDQNCV -KSKL L--- 495 
RBK2 SN-DFREENL-TANCTLANTNYV -1TKLM L--- 499 
Sh H4 STPGLTETHPGRSAVAPFLGAQQQQPQPVASSLSMSIDKQLQHPLQQLTQTQLYQQQQQQQQQQQNGFKQ 607 
Sh H4 QQQQTQQQLQQQQSHTINASAAAATSGSGSSGLTMRHNNALAVSIETDV 656 
Fig. 1 The deduced RHKl amino acid sequence compared with sequences of MBKl, RCK,, RBKZ, and Drosophila Shaker H4 cDNA. Dashes 
represent amino acid identities; gaps are introduced to improve overall alignment; and presumptive transmembrane helices (Sl to S6) are boxed. 
For RHKl, potential phosphorylation sites are marked with a P: CAMP-dependent protein kinase sites 90 and 600, and type II Ca’+/CaM- 
dependent protein kinase sites 90, 101, 122, 190, and 602. Residues 596-602 (KKFRSST) encode an interesting strucfure in RHKl containing both 
PKA and PKC sites. This structure is conserved in MBKl, RCKl, and RBKZ, although the sequences encoding it and the region surrounding it 
are divergent. Shaker H4 only contains the PKA site. Putative N-linked glycosylation sites in RHKl are marked with a dot (residues 182, 353 and 
643). Among them, residue 182 is conserved among other K + channels. Residues 353 and 643 are in two areas of extensive diversity; however, 
glycosylation sites are found in analogous positions in RCKl, RBKZ, MBKl, and Shaker. The RHKl nucleotide sequence is available from the 
Genebank database (M30867). 
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transcription reaction following the manufacturer’s p otocol, except 
for: (i) 1 FCi of [cr-‘*P]LJTP was used instead of 10 PCi, (ii) ATP, 
UTP, and CTP were 0.5 mM, GTP was 0.1 mM, and m7GpppG was 
0.5 mM. Transcribed RNAs were checked with for- 
maldehyde/agarose gel electrophoresis and autoradiography. RNA 
was dissolved in water to 0.2 pg/ml and 50 nl of RNA solution was 
injected into each oocyte. Oocytes were incubated at 20°C in ND96 
(in mM: NaCl96, KC1 2, CaClz 1.8, MgClz 1, and Hepes 5, pH 7.5), 
supplemented with penicillin (100 U/ml), streptomycin (100 m&ml) 
and Na-pyruvate (2.5 mM). For electrophysiology, oocytes were bath- 
ed in Ca’+-free ND96 solution, supplemented with 1.8 mM MgClz, to 
minimize Ca2+ -activated Cl- currents. No time-dependent outward 
currents were observed in uninjected oocytes . Standard 
2-microelectrode voltage clamp was used with 3 M KCl-filled elec- 
trodes (resistance l-2 MB). The gain of the voltage clamp amplifier 
(Dagan 8500) was increased until the capacitative transient was over 
by 2-4 ms and the ratio of membrane voltage step to command 
voltage step was t 0.9 at a step size of 100 mV. Pulse protocol genera- 
tion, data acquisition and analysis were performed on an IBM/AT us- 
ing pClamp software (Axon Instruments). Experiments were carried 
out at room temperature (21-23”(Z). All average values are mean + 
SD. 
3. RESULTS AND DISCUSSION 
A full-length cDNA, RHKl, was isolated from a rat 
heart library using the PCR cloning method as describ- 
ed. The deduced amino acid sequence contains one long 
open reading frame of 654 amino acid residues (cor- 
responding to nucleotides 8 l-2042). The sequence 
reveals an overall structure similar to that described for 
other voltage-gated K + channels with 6 putative 
membrane-spanning segments labeled Sl to S6 in Fig. 1 
[14-15,17-211. RHKl also contains two interesting se- 
quence motifs described previously: the segment S4, 
which may be involved in voltage sensing; and a leucine 
zipper, which may be involved in gating, located bet- 
ween S4 and S5 [22]. As in many other K+ channels, the 
carboxyl-terminus of RHKl ends with the sequence 
TDV. Compared with RCKl, RBK2, MBKl, and 
Shaker H4 channels, RHKl is most highly conserved in 
the presumptive transmembrane segments and the 135 
residues preceding Sl, showing 69-80% amino acid 
identity [14-15,17-191. RHKl shows low homology to 
a recently isolated delayed rectifier (drkl), showing 
38% amino acid identity over the conserved regions 
[23]. The most unusual feature of RHKl is in the 
amino-terminus which is longer than channels RCKl, 
RBK2, and MBKl by some 140 residues and which con- 
tains unusual strings of A, G, R, and E. RHKl is vir- 
tually identical to a recently described rat brain cDNA, 
RCK4 [24]. The two cDNAs appear to be derived from 
the same gene although there are over 30 differences in 
DNA sequences, which may be derived from natural 
variations among rat strains. The most notable dif- 
ferences in the coding region are 2 frameshifts in the 
amino-terminal region (residues 84-88) which reads 
RRRRQ (RHKl) vs EEEAT (RCK4). Other coding dif- 
ferences are at residues 42 (L vs A), 94 (K insertion in 
RCK4), and 309 (A vs G). 
Southern blot analysis under high stringency condi- 
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-6.4 Kb 
-4.3 Kb 
-2.3 Kb 
-2.0 Kb 
9.49 Kb _ 
1.46 Kb - 
4.44 Kb - 
2.37 Kb - 
1.35 Kb - 
0.24 Kb - 
Fig. 2. Southern and Northern blot analysis. (A) RHKl and RCK4 
are probably encoded by the same gene since Southern blot analysis 
under high stringency conditions shows bands of similar sizes 
recognized by the RHKl and RCK4 [24]. (B) Under lowered stringen- 
cies, some additional bands are observed, particularly in digestions 
with PstI (1.8 kb fragment) and PvuII (1.6 kb fragment). The 1.8 kb 
PsrI band resembles one that hybridizes to RCK3 [14]. (C) Expression 
of RHKl is detected in the heart and in the brain by Northern blot 
hybridization under high stringency conditions. 
tions suggests that RHKl is encoded by a single gene, 
i.e. one or two bands are observed in each restriction 
digest of rat genomic DNA (Fig. 2A) [24]. RHKl is ex- 
pressed in heart and brain, but not other tissues (Fig. 
2C). Northern analysis showed that the RHKl probe 
hybridizes to heart and brain poly(A) + RNA of about 
6.0 and 4.5 kb. The 6.0 kb band was present in about 
equal amounts; the 4.5 kb band was relatively more 
abundant in the brain (note, that comparisons are not 
corrected for the proportionately larger amount of 
membrane channel proteins present in brain vs heart) 
[25-261. No hybridization was detected when liver, 
skeletal muscle, spleen, kidney, stomach, and aorta 
RNA was probed with RHKl. The absence of 
transcripts in these tissues, particularly smooth muscle 
and skeletal muscle, is consistent with the absence of the 
transient outward current in these tissues. 
RHKl channel activity was examined in the Xenopus 
oocyte expression system. A transient outward current 
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Fig. 3. Functional features of RHKl channels expressed in Xenopus oocytes. (A) Voltage dependence of activation (upper panel). The insert shows 
current traces induced by 500 ms-depolarizing steps from a holding voltage (Vh) of - 80 mV to test voltages (Vl) ranging from - 60 to + 30 mV, 
in IO-mV increments. Calibration: 25 ms and 1 CA. The plot shows peak current-voltage relationship. Peak current (I,) was the difference between 
the outward peak and the current level 500 ms after the start of depolarization. (Lower panel) Steady state inactivation. Membrane potential was 
stepped from a vh of - 80 mV, to a conditioning voltage (VJ ranging from - 100 to - 10 mV for 2 s, and then to a test pule of + 20 mV. Imax 
is taken as It at V, = - 100 mV (n = 6, symbols represent data from separate xperiments). For each experiment, voltage of half-maximum inactiva- 
tion (Vo.5) and slope factor (k) were determined from the relationship between It/Z ,,,Bx and V, which was best fit by the Boltzmann function 
(11/1m, = 1 + exp[( V, - Vo.s)/k 1) - 1). The smooth curve was calculated from the Boltzmann function using the average of experimental values. (B) 
K + selectivity of the RHKl channel. (Upper panels) The voltage clamp protocol is depicted: membrane potential was stepped from a V,, of - 80 
mV, to + 30 mV for 10 ms, and then to different repolarization voltages (V,) ranging from + 20 to - 120 mV for 500 ms. Also depicted are superim- 
posed tail currents recorded at different [K+],; the marked voltages are those which bracket the reversal potential. At [K’10 of 20 and 40 mM, 
upward deflections caused by overcompensation of the capacitative transient are superimposed on the initial tail currents. Calibration: 7.5 ms and 
500 nA. (Lower left) The plot shows the instantaneous current-voltage relationship for 3 values of [K +lO. Tail current amplitude was determined 
by fitting a single exponential function to the current between 5 and 500 ms after repolarization, and then extrapolating back to the start of the 
repolarization step. Reversal potentials (I&,) were determined by the intersections of the curves with the voltage aixs. (Lower right) Plot shows 
I& at different [K +lO. Symbols represent data from different experiments (n = 3). The straight line is calculated from the Nernst equation, assum- 
ing intracellular [K+]i = 120 mM. For all experiments in this figure, the time between trials was 10 s. 
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was recorded 2-4 days after microinjection of RHKl 
cRNA into oocytes (Fig. 3A). The voltage threshold for 
activation of the RHKl current was - 50 mV; the peak 
current amplitude increased as the voltage became more 
positive up to + 80 mV. The voltage dependence of in- 
activation for RHKl is shown in the steady state inac- 
tivation curve of Fig. 3A. The data from individual 
oocytes were fitted with a Boltzmann function; the 
average half-maximum inactivation voltage (J%,s) was 
- 55.0 f 3.8 mV and the slope factor (k) was 4.2 + 0.8 
mV (n =9). Fig. 3B shows the instantaneous current- 
voltage relationship and reversal potential (I&) of 
RHKl: Erev was - 105, - 45, and -28 mV at 2,20, and 
40 mM [K’],, respectively. Assuming that the channel 
is selective for K+ at 40 mM [K+],, [K+]i is estimated 
to be 120 mM using the Nernst equation and Kiev. Based 
on this estimate of [K+]i, E,,, should be - 104 and 
- 45.5 mV in 2 and 20 mM [K + lo, respectively, close to 
the observed values. Therefore, we suggest hat RHKl 
is a purely K ’ -selective channel. 
The kinetics of activation for RHKl became faster at 
more positive test voltages (Fig. 4), i.e. time to peak was 
14.8 + 4.6 ms at - 20 mV and 11.0 + 3.0 ms at + 30 
mV (n = 6). The time course of current decay was 
described by a single exponential, that was accelerated 
at more positive voltages (Fig. 4). The decay time cons- 
tant was 65.4 f 17.4 and 45,2 + 16.7 ms at -20 and 
+ 30 mV, respectively (n = 6). The recovery from inac- 
tivation followed a single exponential time course in a 
voltage-dependent manner with a time constant of 2.2 
of: 0.6 s (n =6) at - 80 mV (Fig. 4). 
4-AP and Ba2+ blocked the RHKl current with a 
half-maximum inhibition concentration of 1.2 mM and 
0.75 mM, respectively. Cs+ (10 mM) decreased the cur- 
rent by only 10% while tetraethylammonium (20 mM) 
did not affect the current. 
For comparison with the present study, the transient 
outward current in rat ventricular myocytes was studied 
under the same voltage clamp protocols. Properties of 
the transient outward current in rat ventricular 
myocytes are: voltage threshold for activation (-40 
mV); steady-state inactivation (F/o,5 = - 57 mV, k= 4 
mV); time constant of inactivation (30-40 ms at + 60 
mV); time constant of recovery from inactivation (30 
ms at - 80 mV). Also, 4-AP (5 mM) totally abolishes 
the current; Ba2 + (1 mM) decreases the current by 60%; 
and Cs2 + (10 mM) decreases the current by about 10%. 
The functional properties of RHKl are similar to the 
transient outward current in rat ventricular myocytes, 
which is believed to be responsible for phase 1 
repolarization [2]. Indeed, the two currents are virtually 
identical in voltage dependence of activation and inac- 
tivation, kinetics of activation and inactivation, and 
pharmacological sensitivity. The two currents, 
however, differ in recovery from inactivation with the 
ventricular myocyte current recovering more rapidly 
[2]. An interesting possibility is that RHKl is missing an 
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Fig. 4. Kinetic properties of RHKl. (Upper panel) Plot shows 
kinetics of activation and inactivation of RHKl at various test 
voltages (Vf). Voltage clamp protocol is described in the upper panel 
of Fig. 3A. The time to peak current was measured from the start of 
the depolarizing pulse to the peak of I,. The time constant of current 
decay was obtained from a single exponential function fit to the dif- 
ference in current between I, and 200 ms after the start of depolarizing 
pulse. (Lower panel) Plot shows the time course of recovery from in- 
activation at 3 different holding potentials. Voltage clamp protocol 
was a variable interpulse interval (0.01-4.6 s) separating two test 
pulses (+ 20 mV, 100 ms). The time between successive trials was 10 
s. Percent inactivated was the decrease in the peak current amplitude 
between the first and second test pulses. The time course of recovery 
from inactivation was described by a single exponential function. The 
lines were calculated using best-fit time constants: 1.8, 1.6, and 1.3 set 
for vh = - 60, - 80, and - 100 mV, respectively. 
additional subunit that affects recovery from inactiva- 
tion [27], Although RHKl may account for a major 
outward current in the heart, it also shows substantial 
brain expression. An implication is that major chan- 
nels, such as RHKl, represent functions critical for 
several types of excitable membranes. We are presently 
investigating the possibility that other brain channels 
could also show heart expression, with the anticipation 
that a more complete molecular picture of cardiac ex- 
citability may soon be forthcoming. 
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